Sable Offshore (SOC) Offers Impressive Upside Despite Jefferies’ Target Price ReductionJuly 15, 2026Yahoo Finance
Sable Offshore (SOC) Offers Impressive Upside Despite Jefferies’ Target Price ReductionJuly 15, 2026Yahoo Finance
Sable Offshore (SOC) Offers Impressive Upside Despite Jefferies’ Target Price ReductionJuly 15, 2026Yahoo Finance
Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp TherapyJuly 15, 2026Yahoo Finance
Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp TherapyJuly 15, 2026Yahoo Finance
Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp TherapyJuly 15, 2026Yahoo Finance
Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp TherapyJuly 15, 2026Yahoo Finance
Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp TherapyJuly 15, 2026Yahoo Finance
Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp TherapyJuly 15, 2026Yahoo Finance
SAB Biotherapeutics (SABS) and Breakthrough T1D Award Research Grant For SAB-142 AssessmentJuly 15, 2026Yahoo Finance
SAB Biotherapeutics (SABS) and Breakthrough T1D Award Research Grant For SAB-142 AssessmentJuly 15, 2026Yahoo Finance
SAB Biotherapeutics (SABS) and Breakthrough T1D Award Research Grant For SAB-142 AssessmentJuly 15, 2026Yahoo Finance
SAB Biotherapeutics (SABS) and Breakthrough T1D Award Research Grant For SAB-142 AssessmentJuly 15, 2026Yahoo Finance
SAB Biotherapeutics (SABS) and Breakthrough T1D Award Research Grant For SAB-142 AssessmentJuly 15, 2026Yahoo Finance
SAB Biotherapeutics (SABS) and Breakthrough T1D Award Research Grant For SAB-142 AssessmentJuly 15, 2026Yahoo Finance
